Apolipoprotein e ε4 genotype and the morphology of amyloid plaques in Alzheimer's disease

Alzheimer's Reports

Volumn 2, Issue 5, 1999, Pages 267-270

  Oyewole, David ^a   Mann, David Ma ^a   Royston, Maureen C ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011868405     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Berr C, Hauw JJ, Amouyel P et al. (1994). Apolipoprotein E allele ε4 linked to increased deposition of the amyloid β-peptide (Aβ) in cases with and without Alzheimer's disease. Neurosci Left 178, 221-224.
2. Bruce CV, Clinton J, Royston MC et al. (1992). Quantifying the pattern of βA4 amyloid protein distribution in Alzheimers disease by image analysis. Neuropath Appl Neurobiol 18, 125-136
3. Clinton J, Royston MC, Roberts GW et al. (1992). Amyloid plaques: morphology, evolution and etiology. Modern Pathol 5, 439-443.
4. Delaere P, Duyckaerts C, Hauw JJ et al. (1991). Subtypes and differential laminar distributions of βA4 deposits in Alzheimers disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81, 328-335.
5. Edwards RJ, Clinton J, Royston MC et al. (1992). Classification and quantification of plaque types in Alzheimers disease using computerised image analysis. Neurodegeneration 1, 65-71.
6. Gearing M, Mori H, Mirra SS (1996). Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 39, 395-399.
7. Gentleman SM, Perry RM and Roberts GW (1991). Correlations between β-amyloid and mental test scores in Alzheimers disease. Neuropathol Appl Neurobiol 17, 531.
8. Gentleman SM, Bruton C and Roberts GW (1989). A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits. Histochemistry 92, 355-358.
9. Gentleman SM, Williams B, Roberts GW et al. (1992). Quantification of β4 protein deposition in the medialtemporal lobe: a comparison of Alzheimers disease and senile dementia of the Lewy body type. Neurosci Left 142, 9-12.
10. Iwatsubo T, Odaka A, Ihara Y et al. (1994). Visualisation of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13, 45-53.
11. Iwatsubo T, Mann DM, Ihara Y et al. (1995). Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol 37, 294-299.
12. Kitamoto T, Ogomori K,Pruisner SB et al. (1987). Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57, 230-236.
13. Mckenzie JE, Gentleman SM, Roberts GW et al. (1992). Quantification of the medial frontal lobe in patients with Alzheimers disease. Neurosci Lett 143, 23-26.
14. Mann DMA, Esiri MM (1989). The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Downs syndrome. J Neurol Sci 89, 169-179.
15. Mann DM, Iwatsubo T, Perry RH et al. (1997). Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the Apolipoprotein E ε4 allele. Neurosci Lett 17, 81-84.
16. Mahley RW (1988). Apolipoprotein: Cholesterol transport protein with expanding role in cell biology. Science 240, 622-30.
17. Nadel L and Epstein CJ (1992). Progress in Clinical and Biological Research: Down Syndrome and Alzheimer disease. Wiley-Liss, New York.
18. Nalbantoglu J, Gilfix BM, Bertrand P et al. (1994). Predictive value of apolipoprotien E genotyping in Alzheimers disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 36, 889-95.
19. Royston MC, Kodical NS, Roberts GW et al. (1994). Quantification analysis of β-amyloid deposition in Down's syndrome using computerised image analysis. Neurodegeneration 3, 43-51.
20. Schmechel DEA, Saunders AM, Strittmatter WJ et al. (1993). In creased amyloid β-peptide deposition in late onset Alzheimers disease Proc Natl Acad Sci USA 90, 9649-9653.
21. Strittmatter WJ, Wisegraber KH, Roses AD et al. (1993). Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform specific effects and implications for late onset Alzheimers disease. Proc Natl Acad Sci USA 90, 8098-8102.
22. Tierney M, Fisher R and Lewis A (1988). The NINCDS/ADRDA workgroup criteria for the clinical diagnosis of probable Alzheimers disease: a clinico-pathological study of 57 cases. Neurology 38, 359-364.
23. Tomlinson BE and Corsellis JAN (1984). Ageing and the Dementias. In: Greenfields Neuropathology 4th edn. Adams JH, Corsellis JAN and Duchen LW eds. Edward Arnold, London: pp 951-1025.
24. Wenham PR, Price WH and Blundell C (1991). Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159.